FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor
Go back to FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor| Amgen Inc (NASDAQ: AMGN) | Delayed: 347.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $347.01 | 52 Week High | $176.85 | |||
| Open | $347.01 | 52 Week Low | $133.64 | |||
| Day High | $347.01 | P/E | 52.26 | |||
| Day Low | $347.01 | EPS | $6.64 | |||
| Volume | 1,413 | |||||
